Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial

被引：0
|
作者：
Christine Lundgren
Julia Tutzauer
Sarah E. Church
Olle Stål
Maria Ekholm
Carina Forsare
Bo Nordenskjöld
Mårten Fernö
Pär-Ola Bendahl
Lisa Rydén
机构：
[1] Region Jönköping County,Department of Oncology
[2] Linköping University,Department of Biomedical and Clinical Sciences
[3] Lund University,Division of Oncology, Department of Clinical Sciences Lund
[4] NanoString Technologies,Division of Surgery, Department of Clinical Sciences Lund
[5] Inc.,Department of Surgery
[6] Lund University,undefined
[7] Skåne University Hospital,undefined
来源：
Breast Cancer Research | / 25卷
关键词：
Gene expression signatures; Premenopausal; Tamoxifen; Prognostic; Predictive;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial
    Lundgren, Christine
    Tutzauer, Julia
    Church, Sarah E.
    Stal, Olle
    Ekholm, Maria
    Forsare, Carina
    Nordenskjold, Bo
    Ferno, Marten
    Bendahl, Par-Ola
    Ryden, Lisa
    BREAST CANCER RESEARCH, 2023, 25 (01)
  • [2] Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up
    Christine Lundgren
    Pär-Ola Bendahl
    Maria Ekholm
    Mårten Fernö
    Carina Forsare
    Ute Krüger
    Bo Nordenskjöld
    Olle Stål
    Lisa Rydén
    Breast Cancer Research, 22
  • [3] Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up
    Lundgren, Christine
    Bendahl, Par-Ola
    Ekholm, Maria
    Ferno, Marten
    Forsare, Carina
    Kruger, Ute
    Nordenskjold, Bo
    Stal, Olle
    Ryden, Lisa
    BREAST CANCER RESEARCH, 2020, 22 (01)
  • [4] Effects of adjuvant tamoxifen over three decades on breast cancerefree and distant recurrence-free interval among premenopausal women with oestrogen receptor-positive breast cancer randomised in the Swedish SBII:2pre trial
    Ekholm, M.
    Bendahl, P. O.
    Ferno, M.
    Nordenskjold, B.
    Stal, O.
    Ryden, L.
    EUROPEAN JOURNAL OF CANCER, 2019, 110 : 53 - 61
  • [5] Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide
    Harriet Johansson
    Bernardo Bonanni
    Sara Gandini
    Aliana Guerrieri-Gonzaga
    Massimiliano Cazzaniga
    Davide Serrano
    Debora Macis
    Antonella Puccio
    Maria Teresa Sandri
    Marcella Gulisano
    Franca Formelli
    Andrea DeCensi
    Breast Cancer Research and Treatment, 2013, 142 : 569 - 578
  • [6] Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide
    Johansson, Harriet
    Bonanni, Bernardo
    Gandini, Sara
    Guerrieri-Gonzaga, Aliana
    Cazzaniga, Massimiliano
    Serrano, Davide
    Macis, Debora
    Puccio, Antonella
    Sandri, Maria Teresa
    Gulisano, Marcella
    Formelli, Franca
    DeCensi, Andrea
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 142 (03) : 569 - 578
  • [7] Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial
    Alkner, Sara
    Bendahl, Paer-Ola
    Ferno, Marten
    Nordenskjold, Bo
    Ryden, Lisa
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (14) : 2496 - 2502
  • [8] Inference of tamoxifen's effects on prevention of breast cancer from a randomized controlled trial
    Shen, Yu
    Qin, Jing
    Costantino, Joseph R.
    JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 2007, 102 (480) : 1235 - 1244
  • [9] Predictive Value of Molecular Subtypes in Premenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the ABCSG Trial 5
    Bago-Horvath, Zsuzsanna
    Rudas, Margaretha
    Singer, Christian F.
    Greil, Richard
    Balic, Marija
    Lax, Sigurd F.
    Kwasny, Werner
    Hulla, Wolfgang
    Gnant, Michael
    Filipits, Martin
    CLINICAL CANCER RESEARCH, 2020, 26 (21) : 5682 - 5688
  • [10] Switching to anastrozole plus goserelin vs continued tamoxifen for adjuvant therapy of premenopausal early-stage breast cancer: preliminary results from a randomized trial
    Li, Jian-wei
    Liu, Guang-yu
    Ji, Ya-jie
    Yan, Xia
    Pang, Da
    Jiang, Ze-fei
    Chen, De-dian
    Zhang, Bin
    Xu, Bing-he
    Shao, Zhi-ming
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 299 - 307
12345